BillionToOne, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| BLLN | NEO | MYGN | PSNL | RVTY | NTRA | |
|---|---|---|---|---|---|---|
| Market cap | 5.37B | 2.22B | 575.81M | 1.69B | 17.79B | 56.36B |
| P/E (TTM) | 180.8 | — | — | — | 70.9 | — |
| Forward P/E | 76.7 | 54.5 | -10.2 | -16.3 | 26.9 | -2,198.8 |
| Price/book | 9.9 | 2.8 | 1.9 | 6.2 | 2.5 | 30.8 |
| Dividend yield | — | — | — | — | 0.18% | — |
| 1-year change | +1.39% | +61.36% | −8.21% | +105.61% | +76.60% | +94.39% |
| Today | +3.11% | +1.90% | −0.33% | +0.25% | −2.48% | +0.62% |
The closest companies by business and industry (Diagnostics & Research). Prices may be delayed up to 15 min.
Latest news
All BLLN news ›BillionToOne raises 2026 revenue outlook to $460M-$470M while launching Northstar Clear on December 15
BillionToOne Q3 2026 earnings: record revenue, GAAP profit, raised outlook, and NorthStar Clear launch. Earnings Call Insights: BillionToOne (BLLN) Q3 2026 - "In the third quarter, we executed on every one of our 4 pillars. It was another…
BillionToOne Reports Third Quarter 2026 Results and Raises 2026 Revenue Guidance
MENLO PARK, Calif., Nov. 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today reported its financial…
BillionToOne, Inc. GAAP EPS of $0.32 beats by $0.16, revenue of $123M beats by $7.2M
BillionToOne, Inc. press release (BLLN): Q3 GAAP EPS of $0.32 beats by $0.16. Revenue of $123M (+47.3% Y/Y) beats by $7.2M. Financial Outlook BillionToOne now e - BillionToOne, Inc. press release (BLLN): Q3 GAAP EPS of $0.32 beats by…
BillionToOne’s Tissue-Free Northstar Response® Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds
BillionToOneâs Tissue-Free Northstar Response® Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds BillionToOne’s Tissue-Free Northstar Response® Demonstrates On-Par to…
BillionToOne to Participate in Two Upcoming Investor Conferences
A live and archived webcast of the events will be available on the “Events” page of BillionToOne’s investor relations website at https://investors.billiontoone.com/. BillionToOne to Participate in Two Upcoming Investor Conferences MENLO…
BillionToOne announces the launch of Northstar Origin
BillionToOne (BLLN) announced the launch of Northstar Origin, a new liquid biopsy add-on test for tissue-of-origin prediction, along with the ex... BillionToOne announces the launch of Northstar Origin BillionToOne (BLLN) announced the…
Critical Review: Billiontoone (NASDAQ:BLLN) vs. AdaptHealth (NASDAQ:AHCO)
Posted by Sarita Garza on Oct 27th, 2026 AdaptHealth (NASDAQ:AHCO – Get Free Report) and Billiontoone (NASDAQ:BLLN – Get Free Report) are both healthcare companies, but which is the superior stock? We will compare the two companies based…
BillionToOne CEO exercises options, sells shares
BillionToOne, Inc. (NASDAQ: BLLN) is a Menlo Park-based molecular diagnostics company using its QCT platform for prenatal and oncology genetic testing. BillionToOne CEO exercises options, sells shares The chairman and CEO's transactions…
BillionToOne counsel exercises options on 2,000 shares
CytoDyn Appoints Robert E. Hoffman as Chief Executive Officer FreightCar America, Inc. Updates Full-Year 2026 Outlook and Reports Preliminary Third Quarter 2026 Results Tradeweb to Acquire Trumid, Expanding Tradeweb’s Credit Capabilities…
Billiontoone (NASDAQ:BLLN) CEO Sells $516,184.50 in Stock
Oguzhan Atay also recently made the following trade(s): Check Out Our Latest Stock Analysis on Billiontoone BillionToOne, Inc (NASDAQ:BLLN) is a molecular diagnostics company that develops blood-based genetic tests designed to provide more…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- stocktitan.net15
- markets.businessinsider.com6
- marketbeat.com3
- seekingalpha.com2
- themarketsdaily.com2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 35 articles, not a forecast.